# Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia

> **NCT00909584** · PHASE2 · TERMINATED · sponsor: **Telik** · enrollment: 9 (actual)

## Conditions studied

- Severe Chronic Neutropenia

## Interventions

- **DRUG:** Ezatiostat Hydrochloride

## Key facts

- **NCT ID:** NCT00909584
- **Lead sponsor:** Telik
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Study TLK199.2103 was terminated for business reasons.
- **Last updated:** 2013-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00909584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00909584, "Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00909584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*